Assistant Professor, Medicine, University of Colorado School of Medicine
Infectious Disease
Dr. Amie Meditz, MD
|
|
Give Review
Amie Meditz, MD is an expert in the field of Infectious Disease. She studied medicine at University of Texas Southwestern Medical School. She received awards:"CMS Meaningful Use Stage 1 Certification". Dr. Amie Meditz has written publications. She has 28 publications published with PubMed. The lastest publication is: 'Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication.' Doctor Amie Meditz, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots.
- Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication.
- Reduced Immune Activation During Tenofovir-Emtricitabine Therapy in HIV-Negative Individuals.
- Dose-response for Starting and Stopping HIV Pre-Exposure Prophylaxis (PrEP) for MSM.
- Tenofovir Diphosphate in Dried Blood Spots as an Objective Measure of Adherence in HIV-infected Women.
- Safety of Excisional Inguinal Lymph Node Biopsies Performed for Research Purposes in HIV-1-Infected Women and Men.
- CCR5 Expression is Reduced in Lymph Nodes of HIV-1-Infected Women Compared to Men, But Does Not Mediate Sex Differences in Viral Loads.
- Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women.
- Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
- Inadequate T follicular cell help impairs B cell immunity during HIV infection.
- Endothelial Function Is Impaired across the Stages of the Menopause Transition in Healthy Women.
- Tenofovir, emtricitabine, and tenofovir-diphosphate in dried blood spots for determining recent and cumulative drug exposure.
- Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine.
- Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection.
- Concentrations of zidovudine- and lamivudine-triphosphate according to cell type in HIV-seronegative adults.
- Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
- Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection.
- TETRAHYDROBIOPTERIN IMPROVES ENDOTHELIAL FUNCTION AND DECREASES ARTERIAL STIFFNESS IN ESTROGEN-DEFICIENT POSTMENOPAUSAL WOMEN.
- HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.
- Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection.
- Blood myeloid dendritic cells from HIV-1-infected individuals display a proapoptotic profile characterized by decreased Bcl-2 levels and by caspase-3+ frequencies that...
- Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers.
- SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.
- Plasmacytoid and myeloid dendritic cells with a partial activation phenotype accumulate in lymphoid tissue during asymptomatic chronic HIV-1 infection.
- CTL fail to accumulate at sites of HIV-1 replication in lymphoid tissue.
- Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe.
- alpha-Defensins 1, 2, and 3 are expressed by granulocytes in lymphoid tissues of HIV-1-seropositive and -seronegative individuals.
Schools
University Of Texas Southwestern Medical Center At Dallas Southwestern Medical School
University Of Texas Southwestern Medical School Program
University Of Colorado
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Colorado -
University of Texas Southwestern Medical School
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1609899251 | |
| NPPES Provider LastName | MEDITZ | |
| NPPES Provider FirstName | AMIE | |
| NPPES Provider ZIPCode | 803012636 | |
| NPPES Provider State | CO | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 589.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 41.0 | |
| Percent Opioid Claims | 6.96 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1609899251 |
| Last Name Of The Provider | MEDITZ |
| First Name Of The Provider | AMIE |
| View All |
Similar Doctors
|
Dr. Taylor M. Washburn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John D. Beckham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ernest Atlas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Myron J. Levin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacob Gray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew F. Griffith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Maloney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marilyn Levi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Monica Carten, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Misha Huang, MD |
|
|
Dr. Eric P. Richards, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bruce D. McCollister, MD
This Doctor is OpenDoctor Recommended.
|